rogocekib (CTX-712)

News alerts, weekly reports and conference planners

Company:

Chordia Therap

Drug class:

pan-CLK inhibitor

Related drugs:

SRSF2 P95L	Myelodysplastic Syndrome	SRSF2 P95L	Myelodysplastic Syndrome	CTX-712 Sensitive: D – Preclinical CTX-712 Sensitive : D	CTX-712 Sensitive: D – Preclinical CTX-712 Sensitive : D
SRSF2 P95L	Acute Myelogenous Leukemia	SRSF2 P95L	Acute Myelogenous Leukemia	CTX-712 Sensitive: D – Preclinical CTX-712 Sensitive : D	CTX-712 Sensitive: D – Preclinical CTX-712 Sensitive : D
SRSF2 P95H	Myelodysplastic Syndrome	SRSF2 P95H	Myelodysplastic Syndrome	CTX-712 Sensitive: D – Preclinical CTX-712 Sensitive : D	CTX-712 Sensitive: D – Preclinical CTX-712 Sensitive : D

Associations
(3)